L’Oréal Groupe has partnered with the National University of Singapore’s (NUS) Academy for Healthy Longevity at NUS Medicine to advance longevity science research.
The multi-year strategic research partnership between NUS Medicine and the French beauty giant will merge L’Oréal’s expertise in skin and hair science with the university’s knowledge in geroscience and healthy longevity medicine.
The partnership sets out to uncover new insights into the role of skin in “enhancing quality of life from the skin inwards”, facilitated through longevity studies and clinical trials.
Findings from the partnership will feed into L’Oréal’s Longevity Integrative Science, with insights potentially informing the development of evidence-backed interventions for healthier skin, scalp and hair over the long term.
Dr Angeline Tay, Head of Advanced Research at L’Oréal Research & Innovation in Singapore, added: “If signs in the skin turn out to be meaningful indicators about how the whole body is ageing, that changes what a skin measurement really tells us.
“Instead of just reflecting appearance, it could become an early signal of what is happening inside the body.
“This is a hypothesis we believe is worth years of careful, evidence-based research to properly understand, and it is central to our commitment to shifting the science of ageing towards prevention.
“This partnership with NUS Medicine will deepen our understanding of what drives healthy skin ageing, helping us to develop next-generation formulations and routines calibrated to how each person’s skin ages.”
A joint laboratory will open as part of this partnership, dedicated to understanding what skin, scalp and hair reveal about how the body ages.
This research space will enable skin to be “characterised directly from research participants alongside their cardiovascular, metabolic, cognitive and musculoskeletal measures”, read a statement from the university.
These metrics will allow researchers to directly correlate skin data with systemic health indicators.
“Skin has been an underutilised window into the biology of ageing,” said Professor Andrea Maier, Oon Chiew Seng Professor in Medicine, Healthy Ageing and Dementia Research at NUS Medicine, and founder and Director of the NUS Academy for Healthy Longevity at NUS Medicine.
“Our strategic partnership with L’Oréal enables us to integrate state-of-the-art skin assessments into our clinical trials, alongside systemic measures of biological ageing across multiple organ systems.
“This will allow us to better understand how skin reflects and contributes to healthy ageing within the context of the system ageing within persons.”
Lead image: (Left to right) Dr Angeline Tay, Head of Advanced Research at L’Oréal Research & Innovation in Singapore, and Professor Andrea Maier, Oon Chiew Seng Professor in Medicine, Healthy Ageing and Dementia Research at NUS Medicine and founder and Director of the NUS Academy for Healthy Longevity at NUS Medicine, outside the joint laboratory at the Healthy Longevity Clinical Trial Centre. Credit: NUS Medicine
Related content:
- L'Oréal's masterplan to take longevity beauty mainstream
- Is ‘longevity washing’ beauty's next big issue?
- Is longevity the next big beauty category?
- L’Oréal CEO says beauty’s future lies in a ‘new era of longevity’, and he plans to democratise it
- What is the future of anti-ageing in the era of longevity beauty?
- Shiseido unveils research on ring-shaped collagen structure to maintain facial shape
- The science of hair longevity
- Inside Dermalogica’s big innovation plans: longevity science, AI and biotechnology
